Online conference

SCHEDULE.

Conference Opening Event

08:00 am – 08:30 am : Registration & Welcome Coffee
08:30 am – 09:00 am : Daniel Coriu, M.D., Ph.D. Romanian College of Physicians
09:00 am – 9:30 am : Gabriel Ghiaur, M.D., Ph.D. Johns Hopkins University, USA
9:30 am – 10:00 am : AstraZeneca Medical Symposium
Mihnea Zdrenghea, M.D.
Department of Hematology - Iuliu Hatieganu
University of Medicine and Pharmacy, Cluj Napoca, Romania
Consultant Hematologist,
Ion Chiricuta Oncology Institute, Cluj-Napoca, Romania
„New approaches in the management of CLL”
10:00 am – 10:30 am : Victor Greiff, M.D., Ph. D Professor of Immunology, University of Oslo, Norway
10:30 am – 11:10 am : Non-promotional educational
session organized with the support of AbbVie
Horia Bumbea, M.D., Ph.D
University of Medicine and Pharmacy Carol Davila
at the Department of Hematology in the
Emergency University Hospital, Bucharest
"The Future of CLL is Now"
11:10 am – 11:40 am : Astellas Pharma Symposium
Delia Dima, M.D.
Department of Hematology - Iuliu Hatieganu
University of Medicine and Pharmacy, Cluj-Napoca, Romania
11:40 am – 12:10 pm : Leo Luznik, M.D. Johns Hopkins University, USA
12:10 pm – 12:40 pm : Coffee Break
12:40 pm – 1:10 pm : Novartis Symposium
Ciprian Tomuleasa, M.D.
Department of Hematology - Iuliu Hatieganu
University of Medicine and Pharmacy, Cluj-Napoca, Romania
„Jakavi (ruxolitinib) new treatment opportunity for polycythemia vera patients”
1:10 pm – 1:30 pm : Roche Symposium
Ciprian Tomuleasa, M.D.
Department of Hematology - Iuliu Hatieganu
University of Medicine and Pharmacy, Cluj-Napoca, Romania
“Let’s redefine hemophilia A together”
1:30 pm – 2:00 pm : Lunch Break
2:00 pm – 2:30 pm : Novartis Symposium
Delia Dima, M.D.
Department of Hematology - Iuliu Hatieganu
University of Medicine and Pharmacy, Cluj-Napoca, Romania
„Kymriah- first available CAR T therapy in Romania”
2:30 pm – 3:00 pm : Daniela Sauma, M.D., Ph.D. Universidad de Chile, Santiago, Chile
3:00 pm – 3:20 pm : Takeda Symposium
Ciprian Tomuleasa, M.D.
Department of Hematology - Iuliu Hatieganu
University of Medicine and Pharmacy,
Cluj-Napoca, Romania
„Ninlaro (ixazomib) in Real World Evidence (RWE)”
3:20 pm – 3:40 pm : Takeda Symposium
Carmen Escuriola Ettingshausen, M.D.
„Protect Future Joint Health through
Personalization of FVIII Prophylaxis”
3:40 pm – 4:10 pm : Javier Bolaños Meade, M.D. Johns Hopkins University, Baltimore, USA
4:10 pm – 4:40 pm: Janssen Medical Symposium
Delia Dima, M.D.
Department of Hematology - Iuliu Hatieganu
University of Medicine and Pharmacy,
Cluj-Napoca, Romania
"Current clinical practice in multiple myeloma:
long-term outcomes from the first line of treatment."
4:40 pm – 5:10 pm: Janssen Medical Symposium
Mihnea Zdrenghea, M.D.
Department of Hematology - Iuliu Hatieganu
University of Medicine and Pharmacy,
Cluj-Napoca, Romania
Consultant Hematologist, Ion Chiricuta
Oncology Institute, Cluj-Napoca, Romania
"The current management of CLL: old versus new"
5:10 pm – 5:40 pm: Amy Dezern, M.D. Johns Hopkins University, USA
5:40 pm – 6:10 pm : Lukasz Gondek, M.D. Johns Hopkins University, Baltimore, USA
08:00 am – 09:00 am : Registration & Welcome Coffee
9:00 pm - 09:30 pm EUSA Pharma Symposium
Ciprian Tomuleasa, M.D.
Department of Hematology - Iuliu Hatieganu
University of Medicine and Pharmacy, Cluj-Napoca, Romania
09:30 am – 10:00 am : Roche Medical Symposium
Mihnea Zdrenghea, M.D.
Department of Hematology - Iuliu Hatieganu
University of Medicine and Pharmacy, Cluj Napoca, Romania
Consultant Hematologist,
Ion Chiricuta Oncology Institute, Cluj-Napoca, Romania
“New perspectives in RR DLBCL”
10:00 am – 10:30 am : Jo Caers, M.D., Ph.D. University of Liege, Liege, Belgium
Professor of Hematology
Laboratory of Hematology, University of Liege, Liege, Belgium
10:30 am – 11:00 am : Tetiana Skrypets, M.D. Department of Diagnostic Medicine,
Clinical and Public Health,
University of Modena and Reggio Emilia, Italy
11:00 am – 11:30 am : Vernon Louw, M.D., Ph.D. University of the Free State, South Africa
11:30 am – 12:00 pm : Dominik Wolf, M.D. Department Internal Medicine V,
Hematology and Oncology
Medical University of Innsbruck, Austria
"Long term benefits on progression of the Polycythemia Vera with Ropeginterferon alfa-2b"
12:00 pm – 1:00 pm : Alina Tanase, M.D. Fundeni Clinical Institute, Bucharest, Romania
1:00 pm – 1:30 pm : Ling Peng, Ph.D. Equipe Labellisée Ligue Contre le Cancer,
Centre Interdisciplinaire de Nanoscience de Marseille
Aix-Marseille University, Marseille, France
1:30 pm – 2:30 pm : Lunch Break
2:30 pm - 03:00 pm Sobi Symposium
Stefan Lethagen M.D.
Vice president Medical and Clinical Science
Haemophilia Swedish Orphan Biovitrum
"Reshaping haemophilia care with EHLFc coagulation
factor by elevating clinical expectations for
Haemophilia A patients 30min"
3:00 pm - 03:30 pm Pfizer Symposium
Mihaela Andreescu, M.D.
Colentina Clinical Hospital, Bucharest, Romania "The treatment landscape overview in R/R B-ALL"
3:30 pm - 03:50 pm Genesis Pharma Symposium
Ciprian Tomuleasa, M.D.
Department of Hematology - Iuliu Hatieganu
University of Medicine and Pharmacy, Cluj-Napoca, Romania
03:50 am – 04:10 am : Presentation supported by the EEA Financial Mechanism
Ólafur E. Sigurjónsson, M.Sc., Ph.D.
Professor, Department of research and development
The Blood Bank, Landspitali- University Hospital,
Reykjavik University, Reykjavik, Iceland
4:10 pm - 04:30 pm BMS Symposium
Minodora-Cezarina Onisâi M.D.
Bucharest University Emergency Hospital "Myelodysplastic Syndrome: A closer look
at the treatment of ineffective erythropoiesis"
4:30 pm - 04:50 pm BMS Symposium
Sorina Badelita, M.D.
Fundeni Institute Bucharest "Reconsider treatment pathway for relapsed
and refractory multiple myeloma patients"
4:50 pm - 05:20 pm Gianluca Gaidano, M.D., Ph.D. University of Navarra, Italy
5:20 pm - 05:40 pm Ciprian Tomuleasa, M.D. Department of Hematology - Iuliu Hatieganu
University of Medicine and Pharmacy, Cluj-Napoca, Romania
"HE-RO-IS strategic cooperation
in hematology - HERO"